Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11427221 | 0.68 | — | — | |
| Acetic Acid SCHEMBL6063417 | 0.67 | — | — | |
| Allylbenzene SCHEMBL3883984 | 0.67 | ALDH1A1 (0.47) | HSD17B10TSHRSMN1; SMN2PTGS1CYP1A2 | |
| Chavicol SCHEMBL7209702 | 0.64 | CYP1A2 (0.47) | HSD17B10KDM4EGAATSHRSMN1; SMN2 | |
| Allylbenzene SCHEMBL28745662 | 0.63 | ALDH1A1 (0.47) | HSD17B10TSHRSMN1; SMN2PTGS1CYP1A2 | |
| Acetic Acid SCHEMBL9815980 | 0.62 | — | — | |
| Acetic Acid SCHEMBL11750370 | 0.62 | FFAR3 (0.47) | HSD17B10TSHRMAPK1ALDH1A1 | |
| Allyl Alcohol SCHEMBL5083734 | 0.62 | — | — | |
| Acetic Acid SCHEMBL11301717 | 0.60 | FFAR3 (0.44) | HSD17B10TSHRMAPK1ALDH1A1 | |
| Acetic Acid SCHEMBL9217270 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4245122-A | USING TRICAPRYLMETHYLAMMONIUM CHLORIDE AS A PHASE TRANSFER AGENT | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1981-01-13 | — | — | US | claimed |
| US-12013574-B2 | Stable microcapsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2024-06-18 | — | — | US | disclosed |
| EP-3897955-B1 | HYDROXYETHYL CELLULOSE MICROCAPSULES | INT FLAVORS & FRAGRANCES INC (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20240004145-A1 | Stable Microcapsule Compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2024-01-04 | — | — | US | disclosed |
| EP-4209264-A1 | MICROCAPSULE COMPOSITIONS STABILIZED WITH VISCOSITY CONTROL AGENTS | International Flavors & Fragrances Inc. (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20230172820-A1 | Compositions Containing Microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2023-06-08 | — | — | US | disclosed |
| EP-3512625-B1 | MICROCAPSULE COMPOSITIONS STABILIZED WITH VISCOSITY CONTROL AGENTS | INT FLAVORS & FRAGRANCES INC (US) | 2023-04-26 | — | — | EP | disclosed |
| US-11602494-B2 | Compositions containing microcapsules coated with deposition proteins | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2023-03-14 | — | — | US | disclosed |
| US-20230046103-A1 | Stable Microcapsule Compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2023-02-16 | — | — | US | disclosed |
| US-20230051314-A1 | BIODEGRADABLE MICROCAPSULES | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2023-02-16 | — | — | US | disclosed |
| EP-2860237-A1 | Terpolymer-coated polymer encapsulated active material | International Flavors & Fragrances Inc. (US) | 2015-04-15 | — | — | EP | disclosed |
| US-20140044761-A1 | HYBRID FRAGRANCE ENCAPSULATE FORMULATION AND METHOD FOR USING THE SAME | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2014-02-13 | — | — | US | disclosed |
| WO-2013164856-A1 | A PROCESS FOR PREPARING INTERMEDIATES OF 10-PROPARGYL-10-DEAZAAMINOPTERIN (PRALATREXATE) SYNTHESIS AND THE INTERMEDIATES THEREOF | AVRA LABORATORIES PRIVATE LIMITED (IN) | 2013-11-07 | — | — | WO | disclosed |
| US-8119587-B2 | Microcapsules | GIVAUDAN SA (CH) | 2012-02-21 | — | — | US | disclosed |
| EP-2111214-B1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2011-04-13 | — | — | EP | disclosed |
| US-20100009893-A1 | Microcapsules | GIVAUDAN SA (CH) | 2010-01-14 | — | — | US | disclosed |
| EP-2111214-A1 | MICROCAPSULES | Givaudan SA (CH) | 2009-10-28 | — | — | EP | disclosed |
| WO-2008098387-A1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2008-08-21 | — | — | WO | disclosed |
| EP-0364661-A2 | Improved metathesis catalyst system for the polymerization of dicyclopentadiene | HERCULES INCORPORATED (US) | 1990-04-25 | — | — | EP | disclosed |
| US-4167593-A | Method of subbing a polyester base | CIBA-GEIGY AG (CH) | 1979-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230051314-A1 | BIODEGRADABLE MICROCAPSULES | LIPA, MLEC, LRBA | HSD17B10 994/4885KDM4E 3479/4885GAA 529/4885 |
| US-20230172820-A1 | Compositions Containing Microcapsules | COPE, SAAL1, AUP1 | HSD17B10 3654/4885KDM4E 4001/4885GAA 2403/4885 |
| US-12013574-B2 | Stable microcapsule compositions | LIPA, AUP1, PHOSPHO1 | HSD17B10 2842/4885KDM4E 3941/4885GAA 528/4885 |
| US-11602494-B2 | Compositions containing microcapsules coated with deposition proteins | AUP1, CAPG, TTR | HSD17B10 2559/4885KDM4E 4280/4885GAA 2477/4885 |
| US-20140044761-A1 | HYBRID FRAGRANCE ENCAPSULATE FORMULATION AND METHOD FOR USING THE SAME | CUTA, FAU, FHIT | HSD17B10 1575/4885KDM4E 3352/4885GAA 721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.